Cocrystal Pharma COCP
NASDAQ COCP
$1.12 -0.10 (-8.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) EBITDA Margin (2019 - 2026)

Updated

Cocrystal Pharma (COCP) reported EBITDA Margin of -3020.95% for Q2 2026, down 1979.17 percentage points from the prior quarter.

Analysis

Cocrystal Pharma (COCP) EBITDA Margin (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cocrystal Pharma's EBITDA Margin came in at -756.96%; for FY2020, it came in at -468.17%, up 267.78 percentage points from FY2019.

  • By year, EBITDA Margin came in at -735.95% in FY2019.
  • The Q2 2026 figure ranks as the lowest quarterly EBITDA Margin since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Cocrystal Pharma 16.68 Mn -5.22 Mn - -3,020.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,020.95%
Mar 31, 2026 -1,041.78%
Dec 31, 2020 -278.63%
Sep 30, 2020 -544.99%
Jun 30, 2020 -615.88%
Mar 31, 2020 -418.87%
Dec 31, 2019 -11,914.43%
Sep 30, 2019 -362.60%
Jun 30, 2019 -258.11%
Mar 31, 2019 57.11%
API Access

Cocrystal Pharma EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=COCP&period=max&api_key=YOUR_API_KEY